Incidence of gastrointestinal side effects due to alendronate is high in clinical practice

被引：46

作者：

Kelly, R

Taggart, H

机构：

来源：

BRITISH MEDICAL JOURNAL | 1997年 / 315卷 / 7117期

关键词：

D O I：

10.1136/bmj.315.7117.1235a

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1235 / 1235

页数：1

共 5 条

[1] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[2]

*COMM SAF MED, 1996, CURR PROBL PHARM, V22, P5

[3]

GASTELL DO, 1996, NEW ENGL J MED, V335, P1058

[4] PAMIDRONATE - AN UNRECOGNIZED PROBLEM IN GASTROINTESTINAL TOLERABILITY [J].

LUFKIN, EG ;

ARGUETA, R ;

WHITAKER, MD ;

CAMERON, AL ;

WONG, VH ;

EGAN, KS ;

OFALLON, WM ;

RIGGS, BL .

OSTEOPOROSIS INTERNATIONAL, 1994, 4 (06) :320-322

[5]

*MERCK SHARP DOHM, 1996, FOS OES REACT

← 1 →